Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Cancer Discovery|May 10, 2013
Deja Vu: EGF receptors drive resistance to BRAF inhibitorsMaria Romina Girotti, Richard MaraisCancer Discovery|June 5, 2016
So You Can Teach Old Fibroblasts New TricksAmaya Virós, Maria Romina Girotti, Richard MaraisEcancermedicalscience|May 2, 2015
OECI-EACR precision medicine for cancer: Conference report 1-4 March 2015, LuxembourgAnna Golebiewska, Sabrina Fritah, Maria Romina GirottiMolecular Oncology|September 3, 2014
No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patientsMaria Romina Girotti, Grazia Saturno, Paul Lorigan, et al.Trends in Immunology|October 10, 2020
The Paradoxical Roles of Inflammation during PD-1 Blockade in CancerMarcelo Hill, Mercedes Segovia, Sofía Russo, et al.Cytokine & Growth Factor Reviews|December 17, 2009
Matricellular proteins and inflammatory cells: a task force to promote or defeat cancer?Andrea Sabina Llera, Maria Romina Girotti, Lorena Gabriela Benedetti, et al.Cancer Metastasis Reviews|May 7, 2008
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the hostOsvaldo L Podhajcer, Lorena Benedetti, Maria Romina Girotti, et al.Cancer Metastasis Reviews|June 11, 2008
The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the hostOsvaldo L Podhajcer, Lorena Gabriela Benedetti, Maria Romina Girotti, et al.Cancer Cell|April 16, 2015
Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin β1/FAK signalingEishu Hirata, Maria Romina Girotti, Amaya Viros, et al.Ecancermedicalscience|November 21, 2022
Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2Dana Narváez, Federico Waisberg, Tomás Soulé, et al.Pageof 2